Preventing venous thrombo-embolism after nonmajor orthopedic surgery

Charles Marc Samama; Nadia Rosencher; Silvy Laporte; Philippe Girard

doi:10.1016/j.tcm.2020.10.013

Preventing venous thrombo-embolism after nonmajor orthopedic surgery

Trends Cardiovasc Med. 2021 Nov;31(8):507-511. doi: 10.1016/j.tcm.2020.10.013. Epub 2020 Nov 2.

Authors

Charles Marc Samama¹, Nadia Rosencher², Silvy Laporte³, Philippe Girard⁴

Affiliations

¹ Department of Anaesthesia, Intensive Care and Perioperative Medicine, GHU AP-HP, Centre - Université de Paris - Cochin Hospital, 27 rue du Faubourg St Jacques, 75014 Paris, France. Electronic address: [email protected].
² Department of Anaesthesia, Intensive Care and Perioperative Medicine, GHU AP-HP, Centre - Université de Paris - Cochin Hospital, 27 rue du Faubourg St Jacques, 75014 Paris, France.
³ SAINBIOSE U1059, Univ Lyon, UJM-Saint-Etienne, F-42023 Saint-Etienne, France; Unité de Recherche Clinique, Innovation, Pharmacologie, Centre Hospitalier Universitaire de Saint-Etienne, Inserm CIE1408, F-CRIN INNOVTE Network, Paris, France.
⁴ Institut du Thorax Curie-Montsouris, Institut Mutualiste Montsouris, 75014 Paris, France; F-CRIN INNOVTE Network, Paris, France.

PMID: 33152449
DOI: 10.1016/j.tcm.2020.10.013

Abstract

The venous thromboembolism risk is low to moderate in nonmajor orthopedic surgery. The literature is unconclusive. New emerging data are now available. The global patient risk has to be taken into account to determine the need for any prophylaxis.

Keywords: Nonmajor orthopedic surgery; Prophylaxis; Venous thromboembolism.

Publication types

Review

MeSH terms

Anticoagulants / therapeutic use
Embolism* / drug therapy
Humans
Orthopedic Procedures* / adverse effects
Venous Thromboembolism* / drug therapy
Venous Thromboembolism* / epidemiology
Venous Thromboembolism* / prevention & control
Venous Thrombosis* / drug therapy
Venous Thrombosis* / prevention & control

Substances

Anticoagulants